Last reviewed · How we verify
NCT03349593
Prevalence of Hypovolemia and Heart Failure in Non-cardiac Surgery
trial testing Echocardiography in Hypovolemia in 100 participants. Completed in 30 December 2019.
30 November 2018
Quick facts
| Lead sponsor | Umeå University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 December 2017 |
| Primary completion | 30 November 2018 |
| Estimated completion | 30 December 2019 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Echocardiography
Conditions studied
- Hypovolemia — all drugs for Hypovolemia →
- Heart Failure — all drugs for Heart Failure →
- Diastolic Dysfunction — all drugs for Diastolic Dysfunction →
- Systolic Dysfunction — all drugs for Systolic Dysfunction →
Sponsor
Umeå University
Who can join
18 and older, any sex, with Hypovolemia or Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prevalence of biventricular function of the heart and preoperative level of venous return is not known in non-cardiac non-morbid obese population. The aim of the study is to assess the preoperative function of the heart and status of hypovolemia on the day of surgery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pre-operative point-of-care assessment of left ventricular diastolic dysfunction, an observational study.
Stenberg Y, Rhodin Y, Lindberg A, Aroch R, et al · · 2022 · cited 2× · PMID 35382761 · DOI 10.1186/s12871-022-01642-4
Verify or expand the search:
- PubMed search for NCT03349593
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Echocardiography
Trials testing the same drug.
- NCT06863402 — Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype · Phase 2 · recruiting
- NCT07372859 — Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female · NA · not yet recruiting
- NCT06434064 — Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advan · Phase 2 · recruiting
- NCT06871410 — Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia · Phase 1 · recruiting
- NCT07375433 — Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course a · recruiting
Other recruiting trials for Hypovolemia
Currently open trials in the same condition.
- NCT07492511 — Renal and Hepatic Abnormal Doppler Patterns in Trauma · recruiting
- NCT06591234 — Reliability of Internal Jugular Ultrasound : an Observational Transversal Study Conducted Using Images Registered From P · active not recruiting
- NCT05931601 — Early Initiated Vasopressor Therapy in the Emergency Department · Phase 3 · recruiting
Other Umeå University trials
Trials by the same sponsor.
- NCT07407946 — Blended Trauma-Focused Cognitive Behavioral Therapy With Compassion · NA · recruiting
- NCT07346820 — VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation · not yet recruiting
- NCT07417358 — Single-Stapled Technique for Colorectal Anastomosis · recruiting
- NCT07316426 — Preoptimisation in Ventral Hernia Surgery · NA · recruiting
- NCT07170722 — Sub-threshold DRG Stimulation vs Sham in Established Responders · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03349593 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Umeå University
- Last refreshed: 5 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03349593.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing